Breaking News

Sartorius Acquires Stake in AllPure Technologies

Expands portfolio of single-use components for biopharma applications

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sartorius Stedim Biotech (SSB) has signed a contract to acquire majority stake in AllPure Technologies LLC, a start-up company based in New Oxford, PA that specializes in single-use components for biopharma applications. AllPure was established in 2010, and in 2013 had revenues of approximately $3 million with 25 employees. Financial terms were not disclosed.   Reinhard Vogt, member of SSB’s executive board said, “AllPure further completes our portfolio with innovative products that help our cus...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters